APPLICATION OF MULTIVARIATE-ANALYSIS IN PHARMACEUTICAL DEVELOPMENT WORK

被引：20

作者：

LINDBERG, NO ^{[1
]}

LUNDSTEDT, T ^{[1
]}

机构：

[1] STRUCT PROPERTY OPTIMIZAT CTR,S-20180 MALMO,SWEDEN

来源：

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 1995年 / 21卷 / 09期

关键词：

D O I：

10.3109/03639049509069801

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：987 / 1007

页数：21

共 19 条

[11]

RAHMAN AAA, 1992, B PHARM SCI ASSIUT U, V15, P63

[12]

RAYNAUD S, 1985, STP PHARM, V1, P523

[13] KEY VARIABLES IN DOSAGE FORM DESIGN [J].

SCHOFIELD, T ;

BAVITZ, JF ;

LEI, CM ;

OPPENHEIMER, L ;

SHIROMANI, PK .

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (07) :959-974

[14] SCALING-UP OF WET GRANULATION - A STATISTICAL METHODOLOGY [J].

WEHRLE, P ;

NOBELIS, P ;

CUINE, A ;

STAMM, A .

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1993, 19 (16) :1983-1997

[15]

WEHRLE P, 1988, STP PHARMA, V4, P275

[16]

WHITEMAN M, 1992, SPEC PUBL R SOC CHEM, V102, P340

[17] CROSS-VALIDATORY ESTIMATION OF NUMBER OF COMPONENTS IN FACTOR AND PRINCIPAL COMPONENTS MODELS [J].

WOLD, S .

TECHNOMETRICS, 1978, 20 (04) :397-405

[18] PATTERN-RECOGNITION BY MEANS OF DISJOINT PRINCIPAL COMPONENTS MODELS [J].

WOLD, S .

PATTERN RECOGNITION, 1976, 8 (03) :127-139

[19]

ZACEK H, 1987, FOLIA PHARM, V12, P61

← 1 2 →